Similar articles

• Serial determinations of melanoma tumor-associated antigen and antibody in patients with stage I melanoma.

  Wong JH, Gupta RK, Morton DL. Wong JH, et al. Arch Surg. 1986 Nov;121(11):1342-5. doi: 10.1001/archsurg.121.11.1342. Arch Surg. 1986. PMID: 3778209
• Identification and isolation of melanoma-associated antigens with monoclonal antibodies.

  Ross AH, Mitchell KF, Steplewski Z, Koprowski H. Ross AH, et al. Hybridoma. 1982;1(4):413-21. doi: 10.1089/hyb.1.1982.1.413. Hybridoma. 1982. PMID: 6765324
• Melanoma antigens: immunological and biological characterization and clinical significance.

  Herlyn M, Koprowski H. Herlyn M, et al. Annu Rev Immunol. 1988;6:283-308. doi: 10.1146/annurev.iy.06.040188.001435. Annu Rev Immunol. 1988. PMID: 3289568 Review. No abstract available.
• Workshop on monoclonal antibodies to human melanoma-associated antigens: findings of the Seattle group.

  Hellström I, Brown JP, Hellström KE. Hellström I, et al. Hybridoma. 1982;1(4):399-402. doi: 10.1089/hyb.1.1982.1.399. Hybridoma. 1982. PMID: 6208136
• Clinical relevance of immune complexes, associated antigen, and antibody in cancer.

  Salinas FA, Wee KH, Silver HK. Salinas FA, et al. Contemp Top Immunobiol. 1985;15:55-109. doi: 10.1007/978-1-4684-4931-0_2. Contemp Top Immunobiol. 1985. PMID: 3896644 Review. No abstract available.